A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03007888

Recruitment Status : Completed

First Posted : January 2, 2017

Last Update Posted : November 6, 2019

Sponsor:

Information provided by (Responsible Party):

Impax Laboratories, LLC

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	August 1, 2017
Actual Study Completion Date :	August 1, 2017
Certification/Extension First Submitted :	August 15, 2018

To Top